Group One Trading’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54 | Sell |
100
-22,600
| -100% | -$16.6K | ﹤0.01% | 7448 |
|
|
2025
Q4 | $18K | Sell |
22,700
-5,900
| -21% | -$5.8K | ﹤0.01% | 6423 |
|
|
2025
Q3 | $29.7K | Buy |
28,600
+28,100
| +5,620% | +$29.5K | ﹤0.01% | 6377 |
|
|
2025
Q2 | $332 | Sell |
500
-100
| -17% | -$67 | ﹤0.01% | 7699 |
|
|
2025
Q1 | $342 | Sell |
600
-4,200
| -88% | -$3.31K | ﹤0.01% | 7330 |
|
|
2024
Q4 | $4.22K | Buy |
4,800
+600
| +14% | +$802 | ﹤0.01% | 6480 |
|
|
2024
Q3 | $4.62K | Buy |
+4,200
| New | +$9.46K | ﹤0.01% | 5908 |
|
|
2023
Q1 | – | Sell |
-300
| Closed | -$1.49K | – | 7979 |
|
|
2022
Q4 | $1.49K | Sell |
300
-100
| -25% | -$606 | ﹤0.01% | 6740 |
|
|
2022
Q3 | $2K | Buy |
400
+300
| +300% | +$1.93K | ﹤0.01% | 7211 |
|
|
2022
Q2 | $1K | Sell |
100
-480
| -83% | -$2.93K | ﹤0.01% | 7630 |
|
|
2022
Q1 | $3K | Sell |
580
-860
| -60% | -$4.95K | ﹤0.01% | 7655 |
|
|
2021
Q4 | $10K | Sell |
1,440
-780
| -35% | -$7.37K | ﹤0.01% | 7359 |
|
|
2021
Q3 | $24K | Buy |
2,220
+200
| +10% | +$2.35K | ﹤0.01% | 7072 |
|
|
2021
Q2 | $30K | Buy |
2,020
+1,440
| +248% | +$24K | ﹤0.01% | 6959 |
|
|
2021
Q1 | $11K | Sell |
580
-620
| -52% | -$14.9K | ﹤0.01% | 7025 |
|
|
2020
Q4 | $23K | Buy |
1,200
+1,100
| +1,100% | +$18.2K | ﹤0.01% | 5451 |
|
|
2020
Q3 | $1K | Sell |
100
-3,280
| -97% | -$38K | ﹤0.01% | 5964 |
|
|
2020
Q2 | $37K | Buy |
+3,380
| New | +$25.8K | ﹤0.01% | 4541 |
|
|
2016
Q4 | – | Sell |
-40
| Closed | -$3K | – | 4853 |
|
|
2016
Q3 | $3K | Buy |
40
+20
| +100% | +$1.25K | ﹤0.01% | 4323 |
|
|
2016
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 4523 |
|
|
2016
Q1 | $1K | Buy |
+20
| New | +$1.06K | ﹤0.01% | 4456 |
|
|
2015
Q3 | – | Sell |
-20
| Closed | -$2K | – | 5199 |
|
|
2015
Q2 | $2K | Sell |
20
-200
| -91% | -$17.3K | ﹤0.01% | 4678 |
|
|
2015
Q1 | $21K | Sell |
220
-3,000
| -93% | -$277K | ﹤0.01% | 3861 |
|
|
2014
Q4 | $282K | Buy |
3,220
+1,800
| +127% | +$155K | ﹤0.01% | 2020 |
|
|
2014
Q3 | $130K | Buy |
1,420
+600
| +73% | +$65K | ﹤0.01% | 2768 |
|
|
2014
Q2 | $94K | Sell |
820
-120
| -13% | -$14.2K | ﹤0.01% | 3049 |
|
|
2014
Q1 | $114K | Sell |
940
-1,260
| -57% | -$165K | ﹤0.01% | 2958 |
|
|
2013
Q4 | $277K | Buy |
2,200
+720
| +49% | +$86.4K | ﹤0.01% | 2148 |
|
|
2013
Q3 | $161K | Buy |
+1,480
| New | +$144K | ﹤0.01% | 2572 |
|
Other funds holding TRIB
HAIM
YAG
WN
VF
MAWA
IWA
BCM
Group One Trading's TRIB Position: Q4 2023 in Review
Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 3,338 shares — an estimated $12.2K sold.
Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.
- Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
- Group One Trading sold 3,338 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
- Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
- Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
- 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.
Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.